EAS in the News Drugs Archives - Page 3 of 3

RISK MANAGEMENT – FDA’s Quality Risk Management Approach to New Drug Applications

Apr 1, 2019 | Drugs, EAS in the News Drugs

Drug Development and Delivery April 2019 RISK MANAGEMENT – FDA’s Quality Risk Management Approach to New Drug Applications Kaiser...

RISK MANAGEMENT – FDA’s Quality Risk Management Approach to New Drug Applications

Apr 1, 2019 | Drugs, EAS in the News Drugs

Drug Development & Delivery April 2019 RISK MANAGEMENT – FDA’s Quality Risk Management Approach to New Drug Applications Kaiser J....

Homeopathy – What Does the Future Hold?

Mar 4, 2019 | Drugs, EAS in the News Drugs

ISPE iSpeak Blog March 4, 2019 https://ispe.org/pharmaceutical-engineering/ispeak/homeopathy-what-does-future-hold Susan Crane

How GMPs & Data Integrity Align for Safer Products & Swifter Approvals

Jan 23, 2019 | Drugs, EAS in the News Drugs

ISPE iSpeak blog https://ispe.org/pharmaceutical-engineering/ispeak/how-gmps-data-integrity-align-safer-products-swifter-approvals January 23, 2019 Amy Scanlin

Mututal Recognition Agreements and Other FDA Activities for Monitoring the US Drug Product Supply Chain

Oct 1, 2018 | EAS in the News Drugs

Tablets and Capsules https://www.e-digitaleditions.com/i/1035980-tc1018/13? James Evans October 2018